Skip to main content
Log in

High-grade dysplasia within Barrett's esophagus: Controversies regarding clinical opinions and approaches

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Barrett's esophagus with high-grade dysplasia is a well-known risk factor for the development of esophageal adenocarcinoma, which has become the predominant form of esophageal cancer in the United States. This review addresses four major fundamental issues that shape our treatment decisions regarding high-grade dysplasia within Barrett's esophagus: (1) the poorly defined natural history of high-grade dysplasia in its progression to adenocarcinoma, (2) the potentially high morbidity and mortality of esophageal resection for high-grade dysplasia, (3) the difficulty in detecting cancer among dysplastic cells during endoscopy, and (4) the controversial role of endoscopic mucosal ablative therapy for high-grade dysplasia. Until there are more accurate surveillance methods, better biochemical or molecular markers in predicting cancerous progression, or more effective minimally invasive methods of treatment, esophagogastrectomy must be considered the standard means of managing patients with Barrett's esophagus and high-grade dysplasia. Regular rigorous systematic surveillance and endoscopic mucosal ablation are alternative treatment options that are available but should be used only under strict conditions. The decision to proceed in a certain direction is quite complex and challenging and ideally requires the feedback of patients who are properly educated about the controversies surrounding this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bosch A, Frieas Z, Caldwell WL. Adenocarcinoma of the esophagus.Cancer 1979;43:1557–61.

    Article  PubMed  CAS  Google Scholar 

  2. Puestow CB, Gillesby WJ, Guynn VL. Cancer of the esophagus.Arch Surg 1955;70:662–71.

    CAS  Google Scholar 

  3. Turnbull ADM, Goodner JT. Primary adenocarcinoma of the esophagus.Cancer 1968;22:915–8.

    Article  PubMed  CAS  Google Scholar 

  4. Webb JN, Busuttil A.. Adenocarcinoma of the oesophagus and the oesophagogastric junction.Br J Surg 1978;65:475–9.

    Article  PubMed  CAS  Google Scholar 

  5. Gelfand GA, Finley RJ, Nelems B, Inculet R, Evans KG, Fradet G. Transhiatal esophagectomy for carcinoma of the esophagus and cardia. Experience with 160 cases.Arch Surg 1992;127:1164–7.

    PubMed  CAS  Google Scholar 

  6. Putnam JB Jr, Suell DM, McMurtrey MJ, et al. Comparison of three techniques of esophagectomy within a residency training program.Ann Thorac Surg 1994;57:319–25.

    Article  PubMed  Google Scholar 

  7. Rahamim J, Cham CW. Oesophagogastrectomy for carcinoma of the oesophagus and cardia.Br J Surg 1993;80:1305–9.

    Article  PubMed  CAS  Google Scholar 

  8. Blot WJ, Devasa SS, Faumeni JF Jr. Continuing climb in rates of esophageal adenocarcinoma: an update.JAMA 1993;270:1320.

    Article  PubMed  CAS  Google Scholar 

  9. Tytgat GNJ. Does endoscopic surveillance in esophageal columnar metaplasia (Barrett's esophagus) have any real value?.Endoscopy 1995;27:19–26.

    PubMed  CAS  Google Scholar 

  10. Clark GW, Smyrk TC, Burdiles P, et al. Is Barrett's metaplasia the source of adenocarcinomas of the cardia?.Arch Surg 1994;129:609–14.

    PubMed  CAS  Google Scholar 

  11. Haggitt RC, Tryzelaar J, Ellis FH, Colcher H. Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus.Am J Clin Pathol 1978;70:1–5.

    PubMed  CAS  Google Scholar 

  12. Hamillon SR, Smith RRL, Cameron JL. Prevalence and characteristics of Barrett esophagus in patients with adenovarcinoma of the esophagus or esophagogastric junction.Hum Pathol 1988;19:942–8.

    Article  Google Scholar 

  13. MacDonald WC, MacDonald JB. Adenocarcinoma of the esophagus and/or gastric cardia.Cancer 1987;60:1094–8.

    Article  PubMed  CAS  Google Scholar 

  14. Schnell T, Sontag SJ, Chejfec G, et al. High-grade dysplasia is not an indication for surgery in patients with high-grade dysplasia (abstract).Gastroenterology 1996;110:A590.

    Google Scholar 

  15. Levine DS, Haggitt RC, Irvine S, Reid BJ. Natural history of high-grade dysplasia in Barrett's esophagus (abstract).Gastroenterology 1996;110:A550.

    Google Scholar 

  16. Sontag SJ, Schnell TG, Chejfec G, et al. Barrett's, high grade dysplasia: surveillance endoscopy once a year is sufficient in most patients (abstract).Gastroenterology 1999;116:A304.

    Google Scholar 

  17. Weston AP, Sharma P, Topalovski M, Cherian R, Dixon A. Prospective long-term follow-up of Barrett's high-grade dysplasia: risky business (abstract).Gastroenterology 1999;116:A352.

    Google Scholar 

  18. Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low and high risk patient subsets.Am J Gastroenterol 2000;95:1669–76.

    PubMed  CAS  Google Scholar 

  19. Patti MG, Corvera CU, Glasgow RE, Way LW. A hospital's annual rate of esophagectomy influences the operative mortality rate.J Gastrointest Surg 1998;2:186–92.

    Article  PubMed  CAS  Google Scholar 

  20. Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery.JAMA 1998;280:1747–51.

    Article  PubMed  CAS  Google Scholar 

  21. Edwards MJ, Gable DR, Lentsch AB, Richardson JD. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia.Ann Surg 1996;223:586–92.

    Google Scholar 

  22. Pera, M., Trastek VF, Carpenter HA, Allen MS, Deschamps C, Pairolero PC. Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy?.Ann Thorac Surg 1992;54:199–204.

    Article  PubMed  CAS  Google Scholar 

  23. Rice TW, Falk GW, Achkar E, Petras RE. Surgical management of high-grade dysplasia in Barrett's esophagus.Am J Gastroenterol 1993;88:1832–6.

    PubMed  CAS  Google Scholar 

  24. Heitmiller RF, Redmond M, Hamilton SR. Barrett's esophagus with high-grade dysplasia: an indication for prophylactic esophagectomy.Ann Surg 1996;224:67–72.

    Article  Google Scholar 

  25. Lee RG. Dysplasia in Barrett's esophagus. A clinicopathologic study of six patients.Am J Surg Pathol 1985;9:845–52.

    Article  PubMed  CAS  Google Scholar 

  26. Hamilton SR, Smith RL. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus.Am J Clin Pathol 1987;87:301–12.

    PubMed  CAS  Google Scholar 

  27. Reid BJ, Weinstein WM, Lewin KJ, et al. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions.Gastroenterology 1988;94:81–90.

    PubMed  CAS  Google Scholar 

  28. Hameeteman W, Tygat GNJ, Houthoff HJ Van Den Tweel JG. Barrett's esophagus: development and adenocarcinoma.Gastroenterology 1989;96:1249–56.

    PubMed  CAS  Google Scholar 

  29. Altorki NK, Sunagawa M, Little AG, Skinner DB. High-grade dysplasia in the columnar-lined esophagus.Am J Surg 1991; 161:97–100.

    Article  PubMed  CAS  Google Scholar 

  30. Wright TA. High grade dysplasia in Barrett's oesophagus.Br J Surg 1997;84:760–6.

    Article  PubMed  CAS  Google Scholar 

  31. McArdle JE, Lewin KJ, Randall G, Weinstein W. Distribution of dysplasia and early invasive carcinoma in Barrett's esophagus.Hum Pathol 1992;23:479–82.

    Article  PubMed  CAS  Google Scholar 

  32. Levine DS, haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus.Gastroenterology 1993;105:40–50.

    PubMed  CAS  Google Scholar 

  33. Cameron AJ, Carpenter HC, Laukka MA, Trastek VF. Barrett's esophagus: pathologic findings following resection for high-grade dysplasia (abstract).Am J Gastroenterol 1993;88:A8.

    Google Scholar 

  34. Peters JH, Clark GW, Ireland AP, Chandrasoma P, Smyrk TC, DeMeester TR. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients.J Thorac Cardiovasc Surg 1994;108:813–8.

    PubMed  CAS  Google Scholar 

  35. Cameron AJ, Carpenter HC. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study.Am J Gastroenterol 1997;92:586–91.

    PubMed  CAS  Google Scholar 

  36. Falk GW, Rice TW, Goldblum JR, Richter JE. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia.Gastrointest Endosc 1999;49:170–6.

    Article  PubMed  CAS  Google Scholar 

  37. Reid BJ, Blount PL, Feng Z, Levine DS. Optimizing endoscopic biopsy detection of early cancers in Barrett's high grade dysplasia.Am J Gastroenterol 2000;95:3089–96.

    Article  PubMed  CAS  Google Scholar 

  38. Krishnadath KK, Reid BJ, Wang KK. Biomarkers in Barrett esophagus.Mayo Clin Proc 2001;76:438–46.

    PubMed  CAS  Google Scholar 

  39. Reid BJ, Haggitt RC, Rubin CE, et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus.Hum Pathol 1988; 19:166–78.

    Article  PubMed  CAS  Google Scholar 

  40. Wang KK, Sampliner RE. Mucosal ablation therapy of Barrett esophagus.Mayo Clin Proc 2001;76:433–7.

    Article  PubMed  CAS  Google Scholar 

  41. Inoue H, Tani M, Nagai K, et al: Treatment of esophageal and gastric tumors.Endoscopy 1999;31:47–55.

    Article  PubMed  CAS  Google Scholar 

  42. Ell C, May A, Gossner L, et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus.Gastroenterology 2000;118:670–7.

    Article  PubMed  CAS  Google Scholar 

  43. Nijhawan PK, Wang KK. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high grade dysplasia within Barrett's esophagus.Gastrointest Endosc 2000;52:328–32.

    Article  PubMed  CAS  Google Scholar 

  44. Webber J, Herman M., Kessel D, Fromm D. Current concepts in gastrointestinal photodynamic therapy.Ann Surg 1999;230:12–23.

    Article  PubMed  CAS  Google Scholar 

  45. Lightdale CJ, Heier SK, Marcon NE, et al. Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd: YAG laser for palliation of esophageal cancer: a multicenter randomized trial.Gastrointest Endosc, 1995;42:507–12.

    Article  PubMed  CAS  Google Scholar 

  46. Overholt BF, Panjehpour M, Haydek JM. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients.Gastrointest Endosc 1999;49:1–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John F. Gibbs MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Al-kasspooles, M.F., Hill, H.C., Nava, H.R. et al. High-grade dysplasia within Barrett's esophagus: Controversies regarding clinical opinions and approaches. Annals of Surgical Oncology 9, 222–227 (2002). https://doi.org/10.1007/BF02573058

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02573058

Key Words

Navigation